Literature DB >> 3537694

Biochemical characterization of polypeptides encoded by mutated human Ha-ras1 genes.

W W Colby, J S Hayflick, S G Clark, A D Levinson.   

Abstract

We expressed six forms of p21-ras polypeptides in Escherichia coli with differing transformation potentials resulting from amino acid substitutions at position 12. The ability of the encoded p21's to autophosphorylate, bind guanine nucleotides, and hydrolyze GTP was assessed. All versions of p21 bound GTP equivalently; the kinase activity, while dependent upon residue 12, did not correlate with the transforming potential of the polypeptide. All transforming versions exhibited an impaired GTPase activity, while a novel nontransforming derivative [p21(pro-12)] possessed an enhanced GTPase activity. These results provide strong support for the proposal that an impairment of the cellular p21 GTPase activity can unmask its transforming potential.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3537694      PMCID: PMC367567          DOI: 10.1128/mcb.6.2.730-734.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Adenylate cyclase activity in fibroblasts transformed by Kirsten or Moloney sarcoma viruses. Decreased activity and loss of response to prostaglandin E1.

Authors:  W B Anderson; M Gallo; I Pastan
Journal:  J Biol Chem       Date:  1974-11-25       Impact factor: 5.157

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

4.  Homology between human bladder carcinoma oncogene product and mitochondrial ATP-synthase.

Authors:  N J Gay; J E Walker
Journal:  Nature       Date:  1983-01-20       Impact factor: 49.962

5.  Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue.

Authors:  D J Capon; E Y Chen; A D Levinson; P H Seeburg; D V Goeddel
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

6.  Predicted nucleotide-binding properties of p21 protein and its cancer-associated variant.

Authors:  R K Wierenga; W G Hol
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

7.  Guanine nucleotide-binding and autophosphorylating activities associated with the p21src protein of Harvey murine sarcoma virus.

Authors:  T Y Shih; A G Papageorge; P E Stokes; M O Weeks; E M Scolnick
Journal:  Nature       Date:  1980-10-23       Impact factor: 49.962

8.  Altered gene products are associated with activation of cellular rasK genes in human lung and colon carcinomas.

Authors:  C J Der; G M Cooper
Journal:  Cell       Date:  1983-01       Impact factor: 41.582

9.  Characterization of the phosphorylation sites and the surrounding amino acid sequences of the p21 transforming proteins coded for by the Harvey and Kirsten strains of murine sarcoma viruses.

Authors:  T Y Shih; P E Stokes; G W Smythers; R Dhar; S Oroszlan
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

10.  Expression of normal and activated human Ha-ras cDNAs in Saccharomyces cerevisiae.

Authors:  S G Clark; J P McGrath; A D Levinson
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

View more
  18 in total

1.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

Review 2.  The biochemistry of ras p21.

Authors:  R J Grand; D Owen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

3.  Identification of a novel human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation.

Authors:  R Foster; K Q Hu; Y Lu; K M Nolan; J Thissen; J Settleman
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

4.  Oncogenicity of human N-ras oncogene and proto-oncogene introduced into retroviral vectors.

Authors:  M Souyri; I Vigon; M Charon; P Tambourin
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

5.  H-ras mutants lacking the epitope for the neutralizing monoclonal antibody Y13-259 show decreased biological activity and are deficient in GTPase-activating protein interaction.

Authors:  S K Srivastava; A Di Donato; J C Lacal
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

6.  Biochemical and biological properties of the human N-ras p21 protein.

Authors:  M Trahey; R J Milley; G E Cole; M Innis; H Paterson; C J Marshall; A Hall; F McCormick
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

7.  mei-1, a gene required for meiotic spindle formation in Caenorhabditis elegans, is a member of a family of ATPases.

Authors:  S Clark-Maguire; P E Mains
Journal:  Genetics       Date:  1994-02       Impact factor: 4.562

8.  Contributions of intrinsic mutation rate and selfish selection to levels of de novo HRAS mutations in the paternal germline.

Authors:  Eleni Giannoulatou; Gilean McVean; Indira B Taylor; Simon J McGowan; Geoffrey J Maher; Zamin Iqbal; Susanne P Pfeifer; Isaac Turner; Emma M M Burkitt Wright; Jennifer Shorto; Aysha Itani; Karen Turner; Lorna Gregory; David Buck; Ewa Rajpert-De Meyts; Leendert H J Looijenga; Bronwyn Kerr; Andrew O M Wilkie; Anne Goriely
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-20       Impact factor: 11.205

9.  GOPred: GO molecular function prediction by combined classifiers.

Authors:  Omer Sinan Saraç; Volkan Atalay; Rengul Cetin-Atalay
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

10.  Oligodendrocyte RasG12V expressed in its endogenous locus disrupts myelin structure through increased MAPK, nitric oxide, and notch signaling.

Authors:  Haley E Titus; Alejandro López-Juárez; Sadiq H Silbak; Tilat A Rizvi; Madeleine Bogard; Nancy Ratner
Journal:  Glia       Date:  2017-08-30       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.